PALO ALTO, CA, Oct. 17, 2013 /CNW/ - The PAWS Pet Company, Inc.
(OTCQB:PAWS), is pleased to announce that the three short-term
convertible notes that were negotiated with Asher Enterprises, Inc. in
2012 have been paid in full. The final interest payment on the last of
those notes was paid today.
The Company is also taking steps to settle most of the remaining debt on
its books as part of its ongoing process of moving from the pet space
to the pharmaceutical space. Management has received positive responses
from several of these important stakeholders and hopes to finalize this
In further news, the Company believes that an agreement with Pharmacy
Development Inc. dba MESA Pharmacy ("MESA") is in its final stages. The
Company will update shareholders as events warrant.
About The PAWS Pet Company, Inc.
The PAWS Pet Company, Inc. is undergoing a transition from the pet space
to the pharmaceutical space. This exciting transition strategy has been
developed to take advantage of the changes underway in traditional
medical services. PAWS believes that great opportunities exist in
pharmaceuticals and how they are delivered to the public.
For more information on The PAWS Pet Company go to www.thepawspetcompany.com
Company Contact: firstname.lastname@example.org
Certain statements made in this press release are forward-looking in
nature (within the meaning of the Private Securities Litigation Reform
Act of 1995) and, accordingly, are subject to risks and uncertainties.
The actual results may differ materially from those described or
contemplated and consequently, you should not rely on these
forward-looking statements as predictions of future events. Certain of
these risks and uncertainties are discussed in the reports we filed
with the SEC.
SOURCE: The PAWS Pet Company, Inc.
For further information: